Transform Population-Based Screening Into Individual Surveillance
The cancer screening landscape is fragmented and expanding faster than the evidence behind it. Screening tests are not a cancer prevention program. Early detection requires one.
The Screening Gap
In 2026, approximately 2.1 million Americans will be diagnosed with cancer, and about 650,000 will die of it. Furthermore, among adults ages 45-64, cancer now kills more Americans than heart disease.
If every eligible American followed every guideline perfectly, an estimated 570,000 or more people would still die every year.
Routine cancer screening is the floor. Personalized surveillance helps close the gap for the patient in front of you.
Understand Your Patient’s Cancer Risk Profile
The Stage Alpha Assessment determines your patient’s risk profile for the most common cancers, giving you the data to identify which patients would benefit from more frequent surveillance than population-based guidelines.
The assessment combines computational modeling, molecular diagnostics, and precision screening, calibrated to each patient’s individual biology, under the direct oversight of board-certified medical oncologists. You review the findings and decide what comes next for your patient. PreOncology supplies the infrastructure behind that decision.
Your patients get a cancer prevention and early detection program built around their own risk. You get the clinical infrastructure to lead it.
Understand Your Patient’s Cancer Risk Profile
The Stage Alpha Assessment determines your patient’s risk profile for the most common cancers, giving you the data to identify which patients would benefit from more frequent surveillance than population-based guidelines.
The assessment combines computational modeling, molecular diagnostics, and precision screening, calibrated to each patient’s individual biology, under the direct oversight of board-certified medical oncologists. You review the findings and decide what comes next for your patient. PreOncology supplies the infrastructure behind that decision.
Your patients get a cancer prevention and early detection program built around their own risk. You get the clinical infrastructure to lead it.
We Navigate the Noise. You Stay Focused on Your Patients.
The cancer screening landscape is expanding faster than any physician can track. PreOncology does the evaluative work for you, so you are never behind, and your patients always benefit from evidence that has been rigorously evaluated.
- Continuously evaluates emerging technologies against a rigorous, evidence-based grading framework
- Proactively matches the right screening to the right patient at the right interval, and coordinates all clinically indicated testing within the program
- The oncologist-led Signal Board resolves ambiguous signals and false positives and delivers a clear clinical recommendation back to you, so you can communicate what comes next to your patient
Cancer Prevention and Early Detection, Personalized for Your Patients
PreOncology gives your practice an oncologist-supervised cancer prevention and early detection program, built on the Stage Alpha Assessment. PreOncology manages the clinical complexity behind the scenes, so you stay at the center of your patients’ care, understand their cancer risk, and determine next steps for them. Bring advanced cancer prevention and early detection into your practice.
